124 related articles for article (PubMed ID: 11466676)
1. Long term outcome of small size invasive breast carcinomas independent from angiogenesis in a series of 685 cases.
Vincent-Salomon A; Carton M; Zafrani B; Fréneaux P; Nicolas A; Massemin B; Fourquet A; Clough K; Pouillart P; Sastre-Garau X
Cancer; 2001 Jul; 92(2):249-56. PubMed ID: 11466676
[TBL] [Abstract][Full Text] [Related]
2. Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer.
Heimann R; Ferguson D; Powers C; Recant WM; Weichselbaum RR; Hellman S
J Natl Cancer Inst; 1996 Dec; 88(23):1764-9. PubMed ID: 8944007
[TBL] [Abstract][Full Text] [Related]
3. Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma.
Axelsson K; Ljung BM; Moore DH; Thor AD; Chew KL; Edgerton SM; Smith HS; Mayall BH
J Natl Cancer Inst; 1995 Jul; 87(13):997-1008. PubMed ID: 7543156
[TBL] [Abstract][Full Text] [Related]
4. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma.
Weidner N; Folkman J; Pozza F; Bevilacqua P; Allred EN; Moore DH; Meli S; Gasparini G
J Natl Cancer Inst; 1992 Dec; 84(24):1875-87. PubMed ID: 1281237
[TBL] [Abstract][Full Text] [Related]
5. Microvessel quantitation and prognosis in invasive breast carcinoma.
Bosari S; Lee AK; DeLellis RA; Wiley BD; Heatley GJ; Silverman ML
Hum Pathol; 1992 Jul; 23(7):755-61. PubMed ID: 1377162
[TBL] [Abstract][Full Text] [Related]
6. Tumor angiogenesis in node-negative breast carcinomas--relationship with epidermal growth factor receptor, estrogen receptor, and survival.
Fox SB; Leek RD; Smith K; Hollyer J; Greenall M; Harris AL
Breast Cancer Res Treat; 1994 Jan; 29(1):109-16. PubMed ID: 7517221
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of p53, angiogenesis, and other conventional features in operable breast cancer: subanalysis in node-positive and node-negative patients.
Gasparini G; Toi M; Verderio P; Ranieri G; Dante S; Bonoldi E; Boracchi P; Fanelli M; Tominaga T
Int J Oncol; 1998 May; 12(5):1117-25. PubMed ID: 9538138
[TBL] [Abstract][Full Text] [Related]
8. Endothelial area as a prognostic indicator for invasive breast carcinoma.
Simpson JF; Ahn C; Battifora H; Esteban JM
Cancer; 1996 May; 77(10):2077-85. PubMed ID: 8640673
[TBL] [Abstract][Full Text] [Related]
9. Assessment of tumor angiogenesis in invasive breast carcinomas: absence of correlation with prognosis and pathological factors.
Fridman V; Humblet C; Bonjean K; Boniver J
Virchows Arch; 2000 Dec; 437(6):611-7. PubMed ID: 11193472
[TBL] [Abstract][Full Text] [Related]
10. Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma.
Weidner N; Semple JP; Welch WR; Folkman J
N Engl J Med; 1991 Jan; 324(1):1-8. PubMed ID: 1701519
[TBL] [Abstract][Full Text] [Related]
11. Tumor angiogenesis predicts clinical outcome of node-positive breast cancer patients treated with adjuvant hormone therapy or chemotherapy.
Gasparini G; Barbareschi M; Boracchi P; Verderio P; Caffo O; Meli S; Dalla Palma P; Marubini E; Bevilacqua P
Cancer J Sci Am; 1995; 1(2):131-41. PubMed ID: 9166466
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Microvessel Density with Prognostic Factors in Invasive Ductal Carcinomas of the Breast.
Şener E; Şipal S; Gündoğdu C
Turk Patoloji Derg; 2016; 32(3):164-70. PubMed ID: 27562390
[TBL] [Abstract][Full Text] [Related]
13. Angiogenesis and blood vessel invasion as prognostic indicators for node-negative breast cancer.
Kato T; Kameoka S; Kimura T; Nishikawa T; Kasajima T
Breast Cancer Res Treat; 2001 Feb; 65(3):203-15. PubMed ID: 11336242
[TBL] [Abstract][Full Text] [Related]
14. Angiogenesis and tumor grading in primary breast cancer patients: an analysis of 158 needle core biopsies.
Vameşu S
Rom J Morphol Embryol; 2006; 47(3):251-7. PubMed ID: 17308684
[TBL] [Abstract][Full Text] [Related]
15. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.
Pass H; Vicini FA; Kestin LL; Goldstein NS; Decker D; Pettinga J; Ingold J; Benitez P; Neumann K; Rebner M; Dekhne N; Martinez A
Cancer; 2004 Aug; 101(4):713-20. PubMed ID: 15305400
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of angiogenesis evaluated by CD105 expression compared to CD31 in 905 breast carcinomas: correlation with long-term patient outcome.
Dales JP; Garcia S; Andrac L; Carpentier S; Ramuz O; Lavaut MN; Allasia C; Bonnier P; Charpin C
Int J Oncol; 2004 May; 24(5):1197-204. PubMed ID: 15067342
[TBL] [Abstract][Full Text] [Related]
17. Pathologic correlates of prognosis in lymph node-positive breast carcinomas.
Clayton F; Hopkins CL
Cancer; 1993 Mar; 71(5):1780-90. PubMed ID: 8383579
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of vascular endothelial growth factor in breast cancer.
Gasparini G
Oncologist; 2000; 5 Suppl 1():37-44. PubMed ID: 10804090
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of p53 and c-erb B-2 immunostaining is overrated for patients with lymph node negative breast carcinoma: a multivariate analysis of prognostic factors in 613 patients with a follow-up of 14-30 years.
Reed W; Hannisdal E; Boehler PJ; Gundersen S; Host H; Marthin J
Cancer; 2000 Feb; 88(4):804-13. PubMed ID: 10679650
[TBL] [Abstract][Full Text] [Related]
20. Tumor Angiogenesis in Breast Cancer: Pericytes and Maturation Does Not Correlate With Lymph Node Metastasis and Molecular Subtypes.
Shrivastav S; Bal A; Singh G; Joshi K
Clin Breast Cancer; 2016 Apr; 16(2):131-8. PubMed ID: 26452314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
